Phathom Pharmaceuticals reported total assets of $327.07M and total liabilities of $671.35M for the quarter ended Jun 2026, up 30.7% year over year. This balance sheet covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 224.62M | 183.42M | 138.59M | 207.90M | 197.34M | 155.89M | 130.08M | 249.38M | 216.53M | 384.26M | 325.10M | 279.10M | 337.54M | 300.12M | 215.18M | 152.43M | 138.02M | 132.83M | 183.76M | 185.34M | ||||||||||||
| Cash & Current Investments | 224.62M | 183.42M | 138.59M | 207.90M | 197.34M | 155.89M | 130.08M | 249.38M | 216.53M | 384.26M | 325.10M | 279.10M | 337.54M | 300.12M | 215.18M | 152.43M | 138.02M | 132.83M | 183.76M | 185.34M | ||||||||||||
| Receivables - NetNet Receivables | 1.30M | 3.88M | 10.88M | 21.05M | 35.65M | 36.36M | 51.26M | 55.79M | 76.11M | 80.72M | 97.42M | |||||||||||||||||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||||||||
| Receivables | 1.30M | 3.88M | 10.88M | 21.05M | 35.65M | 36.36M | 51.26M | 55.79M | 76.11M | 80.72M | 97.42M | |||||||||||||||||||||
| Raw Materials | 0.11M | 0.11M | 0.56M | 0.64M | 1.30M | 2.02M | 1.73M | 1.44M | 0.99M | 1.01M | 4.06M | 5.03M | 6.22M | |||||||||||||||||||
| Finished Goods | 0.65M | 0.82M | 0.88M | 1.09M | 1.48M | 1.73M | 2.44M | 2.60M | 1.46M | 1.48M | 1.50M | |||||||||||||||||||||
| Inventory | 0.11M | 0.11M | 1.21M | 1.46M | 2.18M | 3.11M | 3.21M | 3.17M | 3.43M | 3.61M | 5.52M | 6.51M | 7.71M | |||||||||||||||||||
| Prepaid Assets | 0.69M | 3.27M | 7.65M | 1.86M | 0.97M | 5.13M | 10.27M | 8.76M | 12.94M | 13.19M | 12.75M | 15.50M | 14.98M | 20.87M | 13.05M | 14.62M | 13.23M | 15.35M | 8.44M | 8.30M | ||||||||||||
| Current Assets | 225.31M | 186.53M | 145.74M | 209.26M | 197.81M | 160.51M | 139.84M | 257.72M | 226.73M | 397.43M | 340.31M | 304.79M | 373.82M | 360.13M | 264.90M | 218.88M | 207.78M | 228.97M | 276.57M | 295.92M | ||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.69M | 0.65M | 0.71M | 0.88M | 0.83M | 1.21M | 1.27M | 1.16M | 1.98M | 2.15M | 1.96M | 1.81M | 1.66M | 1.48M | 1.35M | 1.24M | 1.16M | 1.06M | 1.02M | 0.97M | ||||||||||||
| Long-Term Investments | 8.23M | 8.40M | 7.17M | 6.18M | 11.54M | 23.01M | 24.68M | 24.10M | 20.73M | 19.08M | 21.83M | |||||||||||||||||||||
| Other Non-Current Assets | 0.34M | 0.18M | 0.81M | 0.81M | 0.81M | 0.51M | 0.51M | 3.75M | 3.75M | 2.86M | 2.87M | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 2.92M | 3.09M | 3.09M | ||||||||||||
| Non-Current Assets | 3.06M | 2.90M | 3.31M | 4.25M | 4.12M | 4.30M | 4.17M | 7.32M | 10.27M | 16.41M | 16.18M | 14.59M | 13.22M | 18.18M | 29.31M | 31.34M | 32.51M | 30.18M | 28.55M | 31.16M | ||||||||||||
| Assets | 228.38M | 189.43M | 149.05M | 213.50M | 201.93M | 164.81M | 144.01M | 265.04M | 236.99M | 413.84M | 356.50M | 319.38M | 387.04M | 378.32M | 294.21M | 250.22M | 240.29M | 259.15M | 305.12M | 327.07M | ||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||
| Accounts Payables | 5.58M | 5.15M | 2.86M | 5.76M | 7.13M | 10.00M | 4.80M | 4.17M | 5.79M | 12.60M | 8.40M | 7.66M | 7.13M | 10.51M | 11.62M | 4.01M | 1.07M | 4.98M | 6.37M | 5.36M | ||||||||||||
| Notes Payables | ||||||||||||||||||||||||||||||||
| Payables | 5.58M | 5.15M | 2.86M | 5.76M | 7.13M | 10.00M | 4.80M | 4.17M | 5.79M | 12.60M | 8.40M | 7.66M | 7.13M | 10.51M | 11.62M | 4.01M | 1.07M | 4.98M | 6.37M | 5.36M | ||||||||||||
| Accumulated Expenses | 11.04M | 11.40M | 7.57M | 13.78M | 13.29M | 14.68M | 8.02M | 15.45M | 13.46M | 17.20M | 16.54M | 27.30M | 35.76M | 53.23M | 43.03M | 64.30M | 65.35M | 89.83M | 83.32M | 109.03M | ||||||||||||
| Other Accumulated Expenses | 0.03M | 0.04M | 0.06M | 0.04M | 0.03M | 0.15M | 0.06M | 0.02M | 0.02M | 0.12M | 0.90M | 0.73M | 1.79M | 3.04M | 2.81M | 4.87M | 4.79M | 7.50M | 5.61M | 6.93M | ||||||||||||
| Short term Debt | ||||||||||||||||||||||||||||||||
| Current Leases | 0.48M | 0.49M | 0.49M | 0.63M | 0.69M | 0.71M | 0.71M | 0.72M | 0.72M | 0.73M | 0.73M | 0.72M | 0.68M | 0.50M | 0.32M | 0.24M | 0.59M | 0.65M | 0.67M | 0.67M | ||||||||||||
| Current Deferred Revenue | 0.28M | 2.39M | 7.11M | 16.48M | 9.91M | 20.19M | 19.78M | 17.27M | 21.53M | 24.34M | 27.25M | 33.02M | 37.28M | |||||||||||||||||||
| Total Current Liabilities | 27.81M | 18.92M | 11.39M | 21.07M | 22.88M | 26.24M | 14.44M | 21.55M | 23.98M | 38.78M | 43.46M | 47.01M | 65.29M | 85.73M | 74.03M | 91.82M | 93.12M | 132.04M | 125.04M | 153.78M | ||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||
| Non-Current Debt | 88.31M | 89.67M | 91.04M | 92.43M | 93.88M | 95.26M | 96.64M | 97.81M | 99.26M | 137.84M | 149.02M | 174.42M | 175.73M | 201.41M | 203.25M | 205.14M | 207.09M | 209.09M | 163.68M | 164.59M | ||||||||||||
| Non-Current Deffered Revenue | 109.53M | 119.80M | 123.40M | 299.82M | 302.53M | 321.19M | 322.39M | 333.26M | 343.81M | 347.00M | 348.98M | 350.12M | 347.90M | 347.63M | ||||||||||||||||||
| Operating Leases | 1.28M | 1.18M | 1.08M | 1.39M | 1.25M | 1.10M | 0.94M | 0.79M | 0.63M | 0.46M | 0.29M | 0.13M | 0.59M | 2.12M | 2.06M | 1.96M | 1.85M | |||||||||||||||
| Other Non-Current Liabilities | 7.50M | 7.50M | 7.50M | 7.50M | 7.50M | 7.50M | 7.50M | 7.50M | 7.50M | 9.70M | 9.70M | 10.45M | 10.75M | 11.50M | 11.50M | 11.50M | 11.50M | 4.00M | 3.50M | 3.50M | ||||||||||||
| Total Non-Current Liabilities | 117.40M | 109.78M | 103.51M | 213.00M | 220.85M | 232.12M | 226.71M | 239.94M | 247.26M | 476.90M | 495.30M | 542.75M | 563.41M | 620.40M | 621.08M | 644.55M | 651.32M | 693.32M | 638.58M | 667.85M | ||||||||||||
| Total Liabilities | 124.90M | 117.28M | 111.01M | 220.50M | 228.35M | 239.62M | 234.21M | 247.44M | 254.76M | 486.60M | 505.00M | 553.21M | 574.16M | 631.90M | 632.58M | 656.05M | 662.82M | 697.32M | 642.08M | 671.35M | ||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||
| Total Debt | 88.31M | 89.67M | 91.04M | 92.43M | 93.88M | 95.26M | 96.64M | 97.81M | 99.26M | 137.84M | 149.02M | 174.42M | 175.73M | 201.41M | 203.25M | 205.14M | 207.09M | 209.09M | 163.68M | 164.59M | ||||||||||||
| Common Equity | 103.48M | 72.16M | 38.03M | -7.00M | -26.42M | -74.81M | -90.19M | 17.60M | -17.77M | -72.76M | -148.50M | -233.83M | -187.11M | -253.58M | -338.38M | -405.83M | -422.53M | -438.17M | -336.95M | -344.27M | ||||||||||||
| Liabilities and Shareholders Equity | 228.38M | 189.43M | 149.05M | 213.50M | 201.93M | 164.81M | 144.01M | 265.04M | 236.99M | 413.84M | 356.50M | 319.38M | 387.04M | 378.32M | 294.21M | 250.22M | 240.29M | 259.15M | 305.12M | 327.07M | ||||||||||||
| Retained Earnings | -493.54M | -529.37M | -570.03M | -620.96M | -672.05M | -727.09M | -764.91M | -805.87M | -849.12M | -928.68M | -1011.54M | -1102.98M | -1188.56M | -1263.01M | -1357.33M | -1433.14M | -1463.11M | -1484.26M | -1514.63M | -1532.21M | ||||||||||||
| Treasury Shares | 0.89M | 1.00 | 0.61M | 0.46M | 0.32M | 0.08M | 0.03M | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 |